| Name | Title | Contact Details |
|---|
5strong healthcare is a Short Hills, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Designated “Best of Nursing Homes 2019-2020 - Highest Performing Short-Term Stay” by U.S. News and World Report (Bloomingdale, Chicago Ridge, Elmhurst, La Grange, Lake Zurich, Lombard, Schaumburg) Designated “Best of Nursing Homes 2020” by Newsweek (Bloomingdale) Winner of McKnight`s Long-Term Care News Excellence in Technology "2017 Gold Innovator of the Year" for Curatess Telemedicine Platform Awarded "Best"/Top Performer by U.S. News and World Report: Lexington Health Care Center of Elmhurst Lexington Health Network is Chicagoland`s premier provider of post-acute care & rehabilitation, long-term care, memory care, independent & assisted living, home health care, hospice care and private duty nursing. As the leader of integrated health services, Lexington Health Network is with you, from hospital to home and beyond. Today, Lexington Health Network manages more than 2,000 skilled nursing beds in 10 different post hospital, nursing and long term care buildings as well as more than 500 independent retirement units and more than 150 assisted living units within 3 senior living centers. Our diverse network of health care services also offers home health care, hospice care and private care services. Lexington proudly employs more than 2,500 full and part time individuals enabling us to provide an immeasurable value to the communities we serve. So much of who we are comes from an integrated organization dedicated to the highest attainable quality of care available today. As a family-owned organization, we have always maintained a unique perspective. Whether you are a post-acute patient, resident, a family member, or an employee, you are considered an extension of our family. In an industry filled with rapid change and growth, the Lexington constant, of our commitment to family values, will never change. Welcome to the Lexington Health Network.
Arizona Integrated Physicians is a Peoria, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Mercy Healthcare Group we are committed to serving the needs of small businesses. Whether you are self-employed, an independent contractor, or a small employer with up to 50 employees, we can provide health care coverage for you, your employees and
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.